Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial

BACKGROUND: Tranexamic acid (TXA) is efficacious for reducing blood loss and transfusion use in patients who undergo bilateral TKA, and it is administered intravenously alone, intraarticularly alone, or as a combination of these. However, it is unclear whether combined intravenous (IV) and intraarti...

Full description

Saved in:
Bibliographic Details
Published in:Clin Orthop Relat Res
Main Authors: Meshram, Prashant, Palanisamy, Jeya Venkatesh, Seo, Jong Yeon, Lee, Jong Geun, Kim, Tae Kyun
Format: Artigo
Language:Inglês
Published: Wolters Kluwer 2020
Subjects:
Clinical Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7000050/
https://ncbi.nlm.nih.gov/pubmed/31498264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CORR.0000000000000942
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items